RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+7.3%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.5B
AUM Growth
+$1.5B
(+5.6%)
Cap. Flow
+$28.6M
Cap. Flow
% of AUM
1.9%
Top 10 Holdings %
Top 10 Hldgs %
31.43%
Holding
99
New
7
Increased
28
Reduced
25
Closed
7
Top Buys
| 1 |
Boston Scientific
BSX
|
$14.6M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$12.8M |
| 3 |
Danaher
DHR
|
$11.8M |
| 4 |
Inspire Medical Systems
INSP
|
$10.7M |
| 5 |
Align Technology
ALGN
|
$9.93M |
Top Sells
| 1 |
Abbott
ABT
|
$14.9M |
| 2 |
Thermo Fisher Scientific
TMO
|
$10.6M |
| 3 |
Elevance Health
ELV
|
$10.3M |
| 4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$8.92M |
| 5 |
Biogen
BIIB
|
$8.4M |
Sector Composition
| 1 | Healthcare | 97.82% |
| 2 | Industrials | 1.29% |
| 3 | Technology | 0.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Dynavax Technologies
DVAX
$1.19B
| $10.7M | 0.71% |
750,000
| – | – |
|
52
MeiraGTx Holdings
MGTX
$590M
| $10.5M | 0.7% |
450,000
| – | – |
|
|
53
Align Technology
ALGN
$9.59B
| $9.93M | 0.66% |
+15,000
| New | +$9.93M |
|
54
Health Catalyst
HCAT
$228M
| $9.73M | 0.65% |
240,000
| – | – |
|
55
NovoCure
NVCR
$1.35B
| $9.61M | 0.64% |
120,387
+60,387
| +101% | +$4.82M |
|
56
Harmony Biosciences
HRMY
$2.16B
| $9.53M | 0.63% |
220,000
+15,124
| +7% | +$655K |
|
|
ONEM
57
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $9.2M | 0.61% |
530,000
+110,000
| +26% | +$1.91M |
|
|
SILK
58
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $8.66M | 0.58% |
200,000
+54,000
| +37% | +$2.34M |
|
59
Exact Sciences
EXAS
$9.33B
| $8.57M | 0.57% |
110,000
-70,000
| -39% | -$5.45M |
|
60
Glaukos
GKOS
$5.42B
| $8.02M | 0.53% |
175,000
+25,000
| +17% | +$1.15M |
|
|
OSH
61
DELISTED
Oak Street Health, Inc.
OSH
| $7.72M | 0.51% |
220,000
+115,000
| +110% | +$4.03M |
|
62
Cytokinetics
CYTK
$5.98B
| $6.84M | 0.45% |
+150,000
| New | +$6.84M |
|
|
SWAV
63
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $6.11M | 0.41% |
34,000
| – | – |
|
64
Sangamo Therapeutics
SGMO
$161M
| $5.98M | 0.4% |
765,000
| – | – |
|
65
ESSA Pharma
EPIX
$11.2M
| $5.93M | 0.39% |
420,000
-180,000
| -30% | -$2.54M |
|
|
ISEE
66
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.75M | 0.38% |
350,000
| – | – |
|
|
ACCD
67
DELISTED
Accolade, Inc. Common Stock
ACCD
| $5.52M | 0.37% |
210,000
-115,000
| -35% | -$3.02M |
|
|
AERI
68
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $5.38M | 0.36% |
750,000
| – | – |
|
69
Phreesia
PHR
$1.81B
| $5.24M | 0.35% |
123,465
| – | – |
|
70
Progyny
PGNY
$2.02B
| $5.19M | 0.35% |
101,262
+21,262
| +27% | +$1.09M |
|
71
Stereotaxis
STXS
$246M
| $4.98M | 0.33% |
800,000
| – | – |
|
|
SAGE
72
DELISTED
Sage Therapeutics
SAGE
| $4.97M | 0.33% |
115,000
| – | – |
|
73
Esperion Therapeutics
ESPR
$490M
| $4.96M | 0.33% |
1,000,000
+377,733
| +61% | +$1.87M |
|
74
Alkermes
ALKS
$4.95B
| $4.9M | 0.33% |
210,000
| – | – |
|
75
MacroGenics
MGNX
$121M
| $4.9M | 0.33% |
300,653
-244,507
| -45% | -$3.98M |
|